Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum
- PMID: 2126266
- PMCID: PMC268254
- DOI: 10.1128/jcm.28.12.2674-2680.1990
Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum
Abstract
Nonselective media and previously described selective media were used to study the occurrence of Moraxella (Branhamella) catarrhalis in sputum samples of good and poor quality and in samples taken from different sites of the upper respiratory tracts of healthy subjects. It was found that in healthy adults the carrier rate was 5.4%, as opposed to 50.8% in children and 26.5% in people older than 60 years. M. catarrhalis was recovered significantly more often from sputum samples of good quality (5%) than from poor quality samples (0.5%), and when present, it was found mostly in the presence of high inocula. From these data gathered from healthy and diseased subjects, it is concluded that the presence of M. catarrhalis in the sputum of adults is rarely due to oronasopharyngeal contamination of the sputum. Similar findings reported by others are discussed, and the origins of the currently held concept that M. catarrhalis is a common commensal organism of the human upper respiratory tract are traced.
Similar articles
-
Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections.Med J Aust. 1991 May 6;154(9):592-6. doi: 10.5694/j.1326-5377.1991.tb121219.x. Med J Aust. 1991. PMID: 1905385
-
Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects.Int J Chron Obstruct Pulmon Dis. 2018 Nov 8;13:3663-3667. doi: 10.2147/COPD.S180961. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30510409 Free PMC article.
-
Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.J Med Microbiol. 1997 May;46(5):360-71. doi: 10.1099/00222615-46-5-360. J Med Microbiol. 1997. PMID: 9152030 Review.
-
[Evaluation of a selective medium for the isolation of Moraxella catarrhalis].Enferm Infecc Microbiol Clin. 1992 Aug-Sep;10(7):413-5. Enferm Infecc Microbiol Clin. 1992. PMID: 1450260 Spanish.
-
Moraxella catarrhalis bacteraemia associated with prosthetic vascular graft infection.J Med Microbiol. 2010 Feb;59(Pt 2):245-250. doi: 10.1099/jmm.0.013789-0. Epub 2009 Oct 22. J Med Microbiol. 2010. PMID: 19850707 Review.
Cited by
-
Observations from a multicentre study on the use of the sputum specimen in patients hospitalized with community-acquired pneumonia.Can J Infect Dis. 1999 Jan;10(1):39-46. doi: 10.1155/1999/414595. Can J Infect Dis. 1999. PMID: 22346371 Free PMC article.
-
Oropharyngeal carriage and lower airway colonisation/infection in 45 tracheotomised children.Thorax. 2002 Dec;57(12):1015-20. doi: 10.1136/thorax.57.12.1015. Thorax. 2002. PMID: 12454294 Free PMC article.
-
A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.Clin Diagn Lab Immunol. 1996 May;3(3):351-4. doi: 10.1128/cdli.3.3.351-354.1996. Clin Diagn Lab Immunol. 1996. PMID: 8705682 Free PMC article.
-
The Moraxella catarrhalis phase-variable DNA methyltransferase ModM3 is an epigenetic regulator that affects bacterial survival in an in vivo model of otitis media.BMC Microbiol. 2019 Dec 9;19(1):276. doi: 10.1186/s12866-019-1660-y. BMC Microbiol. 2019. PMID: 31818247 Free PMC article.
-
Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.Thorax. 1998 Feb;53(2):124-8. doi: 10.1136/thx.53.2.124. Thorax. 1998. PMID: 9624298 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources